Get the Stockscreener App
1.46
4.29%
0.06
After Hours:
1.46
Adlai Nortye Ltd Adr stock is traded at $1.46, with a volume of 58,549.
It is up +4.29% in the last 24 hours and up +44.55% over the past month.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
See More
Previous Close:
$1.40
Open:
$1.32
24h Volume:
58,549
Relative Volume:
0.15
Market Cap:
$53.87M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-0.5794
EPS:
-2.5197
Net Cash Flow:
-
1W Performance:
-2.01%
1M Performance:
+44.55%
6M Performance:
-2.67%
1Y Performance:
-25.13%
1-Day Range:
$1.32
$1.47
1-Week Range:
$1.32
$1.53
52-Week Range:
$0.8786
$2.75
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
Compare ANL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANL
Adlai Nortye Ltd Adr
|
1.46 | 51.66M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-04-24 | Initiated | H.C. Wainwright | Buy |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
Adlai Nortye Ltd Adr Stock (ANL) Latest News
Adlai Nortye narrows first-half 2025 loss as oncology pipeline advances - MSN
Adlai Nortye Ltd. Shareholders Approve Redomiciliation to Singapore - MSN
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Xoma (XOMA) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Why Fonar Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Benzinga
Adlai Nortye Ltd ADR (ANL-Q) Stock Price and News - The Globe and Mail
Adlai Nortye licenses cancer drug to ASK Pharm in $230 million deal By Investing.com - Investing.com South Africa
Adlai Nortye shares soar on $230 million licensing deal with ASK Pharm By Investing.com - Investing.com South Africa
Adlai Nortye shares soar on $230 million licensing deal with ASK Pharm - Investing.com India
Adlai Nortye Licenses Pan-RAS Inhibitor AN9025 to ASK Pharm for Greater China - TipRanks
Adlai Nortye licenses cancer drug to ASK Pharm in $230 million deal - Investing.com
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China - Sahm
Adlai Nortye Narrows First-Half 2025 Loss as Oncology Pipeline Advances - TipRanks
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Update - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading 1% HigherWhat's Next? - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading 1% Higher – What’s Next? - Defense World
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Regeneron (REGN) - The Globe and Mail
Adlai Nortye Ltd. Sponsored ADR Cash Flow – LS:A3EEED - TradingView — Track All Markets
Total common shares outstanding of Adlai Nortye Ltd. Sponsored ADR – LS:A3EEED - TradingView — Track All Markets
Analysts Offer Insights on Healthcare Companies: Rigel (RIGL), Terns Pharmaceuticals (TERN) and Pyxis Oncology (PYXS) - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Adicet Bio (ACET), Palvella Therapeutics (PVLA) - The Globe and Mail
Adlai Nortye (NASDAQ:ANL) Shares Down 1.4% – Here’s Why - Defense World
Adlai Nortye (NASDAQ:ANL) Shares Down 1.4%Here's Why - MarketBeat
Adlai Nortye to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Vera Therapeutics (VERA) and Varex Imaging (VREX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Lexicon Pharmaceuticals (LXRX) and Cullinan Management (CGEM) - The Globe and Mail
H.C. Wainwright Reaffirms Their Hold Rating on Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Adlai Nortye Ltd. Plans Redomiciliation to Singapore - MSN
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Short Interest Up 92.3% in September - MarketBeat
HC Wainwright Comments on Adlai Nortye FY2025 Earnings - MarketBeat
Adlai Nortye (NASDAQ:ANL) Trading Down 3.1%Here's Why - MarketBeat
GASFRAC Energy Services (OTCMKTS:GSFVF) Shares Cross Above 200 Day Moving Average – What’s Next? - Defense World
Chart based analysis of Adlai Nortye Ltd. Depositary Receipt trendsQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com
Can technical indicators confirm LZ Technology Holdings Limited’s reversalMarket Weekly Review & AI Powered Market Entry Ideas - newser.com
How to monitor COHU with trend dashboards2025 Geopolitical Influence & Verified Momentum Stock Watchlist - newser.com
Can machine learning forecast Ubiquiti Inc. recoveryQuarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Top chart patterns to watch in ECARX Holdings Inc. Equity WarrantWeekly Trade Summary & Technical Pattern Based Signals - newser.com
Analysts Offer Insights on Healthcare Companies: Intensity Therapeutics, Inc. (INTS), AnaptysBio (ANAB) and Adlai Nortye Ltd. Sponsored ADR (ANL) - The Globe and Mail
Visual analytics tools that track Adlai Nortye Ltd. Depositary Receipt performanceMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Does PBHC show high probability of reboundJuly 2025 Recap & AI Powered Buy and Sell Recommendations - newser.com
Risk vs reward if holding onto Penns Woods Bancorp Inc.2025 Key Highlights & Smart Money Movement Alerts - newser.com
Is MSBI trending in predictive chart modelsQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Short Interest in Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Declines By 65.7% - MarketBeat
Does Bentley Systems Incorporated qualify in momentum factor screening2025 Key Highlights & Consistent Return Investment Signals - newser.com
Earnings visualization tools for WSO.BJuly 2025 Market Mood & Safe Entry Trade Reports - newser.com
Earnings visualization tools for DBRG.PRJQuarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Large Decrease in Short Interest - Defense World
Analysts Set Teradata Corporation (NYSE:TDC) PT at $26.86 - Defense World
Kairos Pharma (KAPA) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Sees Large Increase in Short Interest - MarketBeat
What machine learning models say about Adlai Nortye Ltd. Depositary ReceiptTrade Performance Summary & Verified Chart Pattern Trade Signals - Newser
Using portfolio simulators with Novo Nordisk A s (b Shares) Adrhedged includedJuly 2025 Selloffs & Trade Opportunity Analysis Reports - Newser
Adlai Nortye Ltd Adr Stock (ANL) Financials Data
There is no financial data for Adlai Nortye Ltd Adr (ANL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):